Wegovy is the FDA-approved brand-name semaglutide injection from Novo Nordisk, indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition. At Astra, a US-licensed provider evaluates your medical history through a secure intake and, when appropriate, sends a Wegovy prescription to a partner pharmacy. Your medication ships directly to you with provider support for dosing, side effects, and long-term weight management strategy. Astra does not replace your primary care relationship; we coordinate with your broader care team when needed and provide ongoing telehealth follow-up.
Wegovy (semaglutide) works by mimicking a hormone that targets areas of the brain involved in appetite regulation, helping you feel fuller and reducing calorie intake.
Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. These typically improve over time as your body adjusts to the medication.
Wegovy is a once-weekly injection that you self-administer using a pre-filled pen. We provide complete instructions and ongoing support.
Most patients begin seeing weight loss within the first month, with significant results typically visible after 3-6 months of consistent treatment.
Coverage varies by insurance plan. We can help you navigate insurance options and offer competitive self-pay pricing.
Our clinical providers are Wasef Health, PC c/o Michael Wasef MD. They can be contacted at contact@wasef-health.com. Wasef Health PC has its office located at 5260 78th Ave N, PO Box 1697, Pinellas Park, FL, 33780.
Astra (try-astra.com) is an online telehealth platform offering brand-name and compounded GLP-1 weight loss medications, peptide therapy, and wellness injectables. All Astra services are LegitScript certified and available in 50 US states. Astra is not affiliated with AstraZeneca, Astra Pharma, or any other company using a similar name.